8.65
Schlusskurs vom Vortag:
$8.48
Offen:
$8.53
24-Stunden-Volumen:
2.89M
Relative Volume:
1.22
Marktkapitalisierung:
$1.08B
Einnahmen:
$2.35B
Nettoeinkommen (Verlust:
$-74.42M
KGV:
-9.2021
EPS:
-0.94
Netto-Cashflow:
$150.93M
1W Leistung:
-6.89%
1M Leistung:
-9.71%
6M Leistung:
-62.33%
1J Leistung:
-71.03%
Evolent Health Inc Stock (EVH) Company Profile
Firmenname
Evolent Health Inc
Sektor
Branche
Telefon
571-389-6000
Adresse
800 NORTH GLEBE RD, SUITE 500, ARLINGTON
Vergleichen Sie EVH mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
EVH
Evolent Health Inc
|
8.65 | 1.08B | 2.35B | -74.42M | 150.93M | -0.94 |
![]()
VEEV
Veeva Systems Inc
|
215.78 | 36.24B | 2.75B | 714.14M | 1.09B | 4.33 |
![]()
DOCS
Doximity Inc
|
52.40 | 9.99B | 516.85M | 174.11M | 217.38M | 0.87 |
![]()
TEM
Tempus Ai Inc
|
43.23 | 7.43B | 640.44M | -743.28M | -206.93M | -11.29 |
![]()
HQY
Healthequity Inc
|
83.45 | 7.23B | 1.15B | 96.70M | -161.99M | 1.09 |
![]()
WAY
Waystar Holding Corp
|
35.45 | 6.36B | 906.14M | -52.62M | 89.62M | -0.3621 |
Evolent Health Inc Stock (EVH) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2025-01-10 | Eingeleitet | Needham | Buy |
2024-12-03 | Bestätigt | BTIG Research | Buy |
2024-11-08 | Herabstufung | Stephens | Overweight → Equal-Weight |
2024-10-11 | Eingeleitet | KeyBanc Capital Markets | Overweight |
2024-08-09 | Hochstufung | Truist | Hold → Buy |
2024-04-22 | Eingeleitet | Citigroup | Buy |
2024-03-01 | Eingeleitet | Oppenheimer | Outperform |
2024-01-03 | Eingeleitet | Barclays | Overweight |
2023-12-06 | Eingeleitet | JMP Securities | Mkt Outperform |
2023-10-16 | Eingeleitet | UBS | Buy |
2023-04-12 | Eingeleitet | Stephens | Overweight |
2022-11-01 | Eingeleitet | Truist | Hold |
2022-07-29 | Eingeleitet | RBC Capital Mkts | Outperform |
2022-03-30 | Eingeleitet | Guggenheim | Buy |
2021-11-18 | Hochstufung | JP Morgan | Neutral → Overweight |
2021-04-29 | Fortgesetzt | JP Morgan | Neutral |
2021-01-07 | Eingeleitet | BTIG Research | Buy |
2020-07-06 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
2020-06-05 | Herabstufung | Goldman | Buy → Neutral |
2020-06-02 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
2018-10-05 | Fortgesetzt | Leerink Partners | Outperform |
2018-06-04 | Eingeleitet | Piper Jaffray | Overweight |
2018-04-24 | Fortgesetzt | JP Morgan | Neutral |
2017-09-20 | Eingeleitet | KeyBanc Capital Mkts | Overweight |
2017-06-02 | Eingeleitet | Robert W. Baird | Outperform |
2017-03-14 | Eingeleitet | Oppenheimer | Outperform |
2017-01-13 | Hochstufung | Wells Fargo | Market Perform → Outperform |
2016-10-28 | Fortgesetzt | JP Morgan | Overweight |
2016-08-05 | Bestätigt | FBR Capital | Outperform |
2016-07-26 | Eingeleitet | Jefferies | Buy |
2016-07-13 | Bestätigt | FBR Capital | Outperform |
2016-03-29 | Eingeleitet | FBR Capital | Outperform |
2016-01-06 | Eingeleitet | Canaccord Genuity | Buy |
2015-06-30 | Eingeleitet | Goldman | Buy |
2015-06-30 | Eingeleitet | JP Morgan | Overweight |
2015-06-30 | Eingeleitet | Leerink Partners | Outperform |
2015-06-30 | Eingeleitet | Sun Trust Rbsn Humphrey | Buy |
Alle ansehen
Evolent Health Inc Aktie (EVH) Neueste Nachrichten
Evolent Health Nominates Shawn Guertin to Board - TipRanks
Evolent names Shawn Guertin as new independent nominee for election to its Board of Directors | EVH Stock News - GuruFocus
Evolent Names Shawn Guertin As New Independent Nominee For Election To Its Board Of Directors - marketscreener.com
Healthcare Finance Veteran Shawn Guertin Brings 40-Year Experience to Evolent Board Nomination - Stock Titan
Molina Healthcare, Encompass Health, RadNet, Evolent Health, and Ibotta Shares Are Falling, What You Need To Know - Yahoo Finance
Analysts’ Top Healthcare Picks: Evolent Health (EVH), Gilead Sciences (GILD) - The Globe and Mail
Evolent Health Insiders Placed Bullish Bets Worth US$1.35m - Yahoo
Evolent program achieves 20% reduction in use of low-value oncol - GuruFocus
Healthcare Breakthrough: Evolent Slashes Expensive Cancer Treatment Costs While Maintaining Care Quality - Stock Titan
Benign Growth For Evolent Health, Inc. (NYSE:EVH) Underpins Its Share Price - simplywall.st
Evolent To Release First Quarter 2025 Financial Results on Thurs - GuruFocus
Evolent Health (EVH) Price Target Lowered by Truist Analyst Amid Market Uncertainty | EVH Stock News - GuruFocus
Evolent To Release First Quarter 2025 Financial Results on Thursday, May 8, 2025 - The Malaysian Reserve
The Analyst Verdict: Evolent Health In The Eyes Of 16 Experts - Benzinga
1 Growth Stock to Stash and 2 to Keep Off Your Radar - The Globe and Mail
Evolent Health price target lowered to $14 from $15 at Truist - TipRanks
Truist Cuts Price Target on Evolent Health to $14 From $15, Keeps Buy Rating - marketscreener.com
Indo-Asian News Service - Indo-Asian News Service (IANS)
Evolent Health Sets Q1 Earnings Date: Key Financial Results and Conference Details Ahead - Stock Titan
Evolent Health, Inc. (NYSE:EVH) Receives $17.71 Consensus Target Price from Brokerages - MarketBeat
KeyBanc sees PRVA acquisition of EVH’s MSSP as unlikely but instructive - Investing.com Australia
Evolent Health, Inc. (EVH): Among Stocks Insiders Were Buying In Q1 2025 - Yahoo
20 Stocks Insiders Were Buying In Q1 2025 - Insider Monkey
Is Evolent Health (EVH) About to Explode? - Insider Monkey
12 Stocks That Are About to Explode - Insider Monkey
Here’s What Challenged Evolent Health (EVH) Despite Strong Revenue Growth - Insider Monkey
Evolent Health (NYSE:EVH) shareholders have endured a 69% loss from investing in the stock a year ago - Yahoo Finance
When the Price of (EVH) Talks, People Listen - Stock Traders Daily
1 Healthcare Stock on Our Watchlist and 2 to Turn Down - The Globe and Mail
Evolent Health (EVH): Among Stocks Insiders Are Buying In March - Insider Monkey
Evolent Health Co-Founder Acquires 13% More Stock - simplywall.st
10 Stocks Insiders Are Buying In March - Insider Monkey
Q4 Earnings Review: Healthcare Technology for Providers Stocks Led by Phreesia (NYSE:PHR) - The Globe and Mail
Cardinal Health Adds Two Members to Its Board of Directors - HME Business
Commit To Buy Evolent Health At $7.50, Earn 22.1% Annualized Using Options - Nasdaq
Define Ventures Appoints Carolyn Magill as Venture Partner - Quantisnow
Healthcare Powerhouse Carolyn Magill Joins $800M Define Ventures Leadership Team - StockTitan
Evolent Health (NYSE:EVH) Given New $12.00 Price Target at JPMorgan Chase & Co. - Defense World
Evolent Health, Inc. (NYSE:EVH) Receives Average Rating of “Buy” from Analysts - Defense World
Evolent health director Brendan Springstubb acquires $139,050 in stock By Investing.com - Investing.com South Africa
Evolent Health director Keck Kim buys $99,497 in stock By Investing.com - Investing.com South Africa
Evolent Health director Glass Russell Monroe acquires $50,058 in stock By Investing.com - Investing.com South Africa
Beyond The Numbers: 18 Analysts Discuss Evolent Health Stock - Benzinga
Evolent health director Peter Grua acquires $99,470 in shares By Investing.com - Investing.com Australia
Evolent Health CEO Seth Blackley purchases $497,577 in stock By Investing.com - Investing.com South Africa
Evolent Health president Daniel McCarthy buys $99,470 in stock By Investing.com - Investing.com Canada
Evolent health director Diane Holder buys shares worth $25,517 By Investing.com - Investing.com South Africa
Evolent Health director Glass Russell Monroe acquires $50,058 in stock - Investing.com
Evolent Health director Craig Barbarosh buys $17,620 in stock By Investing.com - Investing.com South Africa
Evolent Health president Daniel McCarthy buys $99,470 in stock - Investing.com India
Evolent health director Diane Holder buys shares worth $25,517 - Investing.com India
Finanzdaten der Evolent Health Inc-Aktie (EVH)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):